IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorEgymedicalpedia
About this trial
Polycystic ovarian syndrome (PCOS) occurs in 5% to 10% of all women of reproductive age and 50% of women who present with sub-fertility due to anovulatory infertility . Clear diagnostic criteria for this condition were identified at the consensus meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine .
Eligibility criteria
Qualifiers
Oligo-ovulation or anovulation.
Clinical and/or biochemical hyper androgenesim.
Polycystic ovaries.
Disqualifiers
Androgen-secreting tumors (ovarian or adrenal).
Adult-onset congenital adrenal hyperplasia.
Thyroid diseases.
Cushing's syndrome.
Trial design
Treatments tested in this trial
- the pregnancy rate at IVF / ICSI cycles
Treatment groups
156 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov